These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19161279)

  • 21. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
    J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations.
    Pastorin G; Da Ros T; Bolcato C; Montopoli C; Moro S; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
    J Med Chem; 2006 Mar; 49(5):1720-9. PubMed ID: 16509587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
    Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
    J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine A(3) receptor mediated coronary vasodilation in the rat heart: changes that occur with maturation.
    Jenner TL; Rose'meyer RB
    Mech Ageing Dev; 2006 Mar; 127(3):264-73. PubMed ID: 16309733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.
    Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Brussee J; Ijzerman AP
    J Med Chem; 2006 May; 49(10):2861-7. PubMed ID: 16686529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
    Tränkle C; Kostenis E; Burgmer U; Mohr K
    J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
    J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-[omega-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands.
    Lacivita E; Leopoldo M
    J Med Chem; 2008 Mar; 51(5):1492-5. PubMed ID: 18269229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubility.
    Chen J; Ding K; Levant B; Wang S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):443-6. PubMed ID: 16290142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-affinity relationships of adenosine A2B receptor ligands.
    Beukers MW; Meurs I; Ijzerman AP
    Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.
    Gao ZG; Van Muijlwijk-Koezen JE; Chen A; Müller CE; Ijzerman AP; Jacobson KA
    Mol Pharmacol; 2001 Nov; 60(5):1057-63. PubMed ID: 11641434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor.
    Heitman LH; Narlawar R; de Vries H; Willemsen MN; Wolfram D; Brussee J; Ijzerman AP
    J Med Chem; 2009 Apr; 52(7):2036-42. PubMed ID: 19296599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.
    Priego EM; Pérez-Pérez MJ; von Frijtag Drabbe Kuenzel JK; de Vries H; Ijzerman AP; Camarasa MJ; Martín-Santamaría S
    ChemMedChem; 2008 Jan; 3(1):111-9. PubMed ID: 18000937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
    Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
    J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
    Chordia MD; Zigler M; Murphree LJ; Figler H; Macdonald TL; Olsson RA; Linden J
    J Med Chem; 2005 Aug; 48(16):5131-9. PubMed ID: 16078833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?
    Schwartz TW; Holst B
    Trends Pharmacol Sci; 2007 Aug; 28(8):366-73. PubMed ID: 17629958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.